[HTML][HTML] Remdesivir and its antiviral activity against COVID-19: A systematic review
Background To summarize the antiviral activities of remdesivir against SARS-CoV-2, the
causative agent of COVID-19. Methods Available publications were systematically explored …
causative agent of COVID-19. Methods Available publications were systematically explored …
[HTML][HTML] Ivermectin as a potential drug for treatment of COVID-19: an in-sync review with clinical and computational attributes
H Kaur, N Shekhar, S Sharma, P Sarma… - Pharmacological …, 2021 - Springer
Introduction COVID-19 cases are on surge; however, there is no efficient treatment or
vaccine that can be used for its management. Numerous clinical trials are being reviewed for …
vaccine that can be used for its management. Numerous clinical trials are being reviewed for …
[HTML][HTML] Evaluation of the effectiveness and safety of adding ivermectin to treatment in severe COVID-19 patients
N Okumuş, N Demirtürk, RA Çetinkaya, R Güner… - BMC infectious …, 2021 - Springer
Background and objectives An effective treatment option is not yet available for SARS-CoV2,
which causes the COVID-19 pandemic and whose effects are felt more and more every day …
which causes the COVID-19 pandemic and whose effects are felt more and more every day …
[HTML][HTML] Impacto del confinamiento por COVID-19 en la calidad de vida y salud mental
CL Ballena, L Cabrejos, Y Davila… - Revista del Cuerpo …, 2021 - scielo.org.pe
Introducción: La pandemia por SARS-Cov-2 ha tenido un impacto negativo en múltiples
aspectos de la vida humana, tanto en lo físico, psicológico, económico, social y cultural. Las …
aspectos de la vida humana, tanto en lo físico, psicológico, económico, social y cultural. Las …
Corona viruses: a review on SARS, MERS and COVID-19
NN Chathappady House, S Palissery… - Microbiology …, 2021 - journals.sagepub.com
After the outbreak of SARS and MERS, the world is now in the grip of another viral disease
named COVID-19 caused by a beta Coronavirus–SARS COV-2 which appears to be the …
named COVID-19 caused by a beta Coronavirus–SARS COV-2 which appears to be the …
[HTML][HTML] Repurposing of antibiotics for clinical management of COVID-19: a narrative review
Background Drug repurposing otherwise known as drug repositioning or drug re-profiling is
a time-tested approach in drug discovery through which new medical uses are being …
a time-tested approach in drug discovery through which new medical uses are being …
[HTML][HTML] Knowledge, attitude, and practice regarding COVID-19 among healthcare workers in primary healthcare centers in Dubai: a cross-sectional survey, 2020
AH Albahri, SA Alnaqbi, SA Alnaqbi… - Frontiers in Public …, 2021 - frontiersin.org
Introduction: The coronavirus disease 2019 (COVID-19) pandemic continues to challenge
healthcare services worldwide. Healthcare workers (HCWs) are key to the continued effort to …
healthcare services worldwide. Healthcare workers (HCWs) are key to the continued effort to …
[HTML][HTML] Challenges to antimicrobial stewardship in the countries of the Arab League: concerns of worsening resistance during the COVID-19 pandemic and proposed …
NA Rizk, R Moghnieh, N Haddad, MC Rebeiz… - Antibiotics, 2021 - mdpi.com
The COVID-19 pandemic is expected to worsen the global problem of antimicrobial
resistance (AMR). There is a heightened interest in understanding this effect and to develop …
resistance (AMR). There is a heightened interest in understanding this effect and to develop …
Current status and strategic possibilities on potential use of combinational drug therapy against COVID-19 caused by SARS-CoV-2
The spread of new coronavirus infection starting December 2019 as novel SARS-CoV-2,
identified as the causing agent of COVID-19, has affected all over the world and been …
identified as the causing agent of COVID-19, has affected all over the world and been …
Therapeutic drugs for SARS-CoV-2 treatment: Current state and perspective
The disease caused by viral pneumonia called severe acute respiratory syndrome
coronavirus type-2 (SARS-CoV-2) declared by the World Health Organization is a global …
coronavirus type-2 (SARS-CoV-2) declared by the World Health Organization is a global …